Post-IPO Equity Life Science Companies

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

ArriVent develops pharmaceutical products to cure presently untreatable cancer.